KAIROS PHARMA LTD (KAPA)

US48301N1046 - Common Stock

1.51  -0.62 (-29.11%)

Premarket: 1.31 -0.2 (-13.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
N/AN/AN/A
EBITDA
YoY % growth
-1.845M-411K
77.72%		-1.554M
-278.10%		N/AN/AN/A
EBIT
YoY % growth
-1.943M-571K
70.61%		-1.714M
-200.18%		N/A
42.63%		N/A
-211.20%		N/A
-300.00%
Operating Margin
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A
-130.00%		N/A
-95.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.02
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-229.5K
78.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0% N/A
RevenueN/A N/A N/A N/A